Xin Tao

Xin's background in life science (biochemistry and molecular genetics) assists him in his science-based food and drug law practices. Xin advises clients on food and drug law with a particular focus on food ingredients, dietary supplements, and food and pharmaceutical packaging materials.

Xin has helped numerous food, dietary supplement, and pharmaceutical companies evaluate the need for marketing approval from the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA). He also pursues clearance or pre-market approval when necessary and responds to FDA enforcement activities. Xin has advised numerous companies on issues relating to the advertising and promoting of products including the Federal Trade Commission (FTC)'s claim substantiation standards. Xin also has vast experience with FDA and USDA due diligence investigations for companies subject to takeover or merger activity. He assists with finalizing deals and identifies regulatory deficiencies. He is increasingly expanding his knowledge of California's Proposition 65 as it pertains to his clients.